Direct-to-consumer cancer testing could be beneficial, expert says, but it's not a substitute
The biotechnology company 23andMe was recently given the green light by the Food and Drug Administration to make direct-to-consumer genetic testing for cancer risk available to the public. The test seeks to identify three ...
Mar 28, 2018
0
5